MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,778 Cr | ₹1,293 Cr | ₹1,110 Cr | ₹1,070 Cr | ₹858 Cr |
What is the latest Total Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,778 Cr |
| Mar2024 | ₹1,293 Cr |
| Mar2023 | ₹1,110 Cr |
| Mar2022 | ₹1,070 Cr |
| Mar2021 | ₹858 Cr |
How is Total Liabilities of MOREPEN LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,778 Cr | 37.50 | |
| Mar2024 | ₹1,293 Cr | 16.45 | |
| Mar2023 | ₹1,110 Cr | 3.78 | |
| Mar2022 | ₹1,070 Cr | 24.69 | |
| Mar2021 | ₹858 Cr | - | |
Compare Total Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹2,912.1 Cr | 7.2% | 20.9% | -13.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | 7.2% |
20.9% |
-13.5% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses